AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
12.61
-0.03 (-0.24%)
At close: Oct 13, 2026, 4:00 PM EDT
12.60
-0.01 (-0.08%)
After-hours: Oct 13, 2026, 7:57 PM EDT
AbCellera Biologics Operating Metrics
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Programs Under Contract | - | - | - | - | - | 739.00 | 710.00 | 692.00 | 679.00 | 660.00 | 642.00 | 633.00 | 607.00 | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
| Programs Under Contract Growth | - | - | - | - | - | 11.97% | 10.59% | 9.32% | 11.86% | 16.20% | 24.66% | 39.43% | 54.85% | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
| Partnered Program Starts | - | - | - | - | - | 404.00 | 392.00 | 374.00 | 356.00 | 339.00 | 342.00 | 319.00 | 291.00 | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
| Partnered Program Starts Growth | - | - | - | - | - | 19.17% | 14.62% | 17.24% | 22.34% | 29.89% | 45.53% | 47.00% | 41.95% | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
| Number of Discovery Partners | - | - | - | - | - | 170.00 | 164.00 | 160.00 | 157.00 | 152.00 | 148.00 | 145.00 | 140.00 | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
| Number of Discovery Partners Growth | - | - | - | - | - | 11.84% | 10.81% | 10.34% | 12.14% | 14.29% | 19.35% | 26.09% | 30.84% | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
| Number of Molecules in the Clinic | 60.00 | 57.00 | 54.00 | 50.00 | 45.00 | 41.00 | 36.00 | 33.00 | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
| Number of Molecules in the Clinic Growth | 33.33% | 39.02% | 50.00% | 51.52% | 50.00% | 51.85% | 50.00% | 50.00% | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Licensing | 36.65M | 46.94M | 46.92M | 11.03M | 11.11M | 1.04M | 1.05M | 953.00K | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
| Licensing Growth | 229.84% | 4,431.27% | 4,372.83% | 1,057.50% | 1,106.41% | 33.33% | 8.26% | 0.53% | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
| Research Fees | 28.53M | 31.26M | 27.21M | 24.29M | 21.76M | 20.58M | 26.28M | 30.26M | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
| Research Fees Growth | 31.07% | 51.93% | 3.52% | -19.72% | -28.37% | -40.80% | -26.08% | -20.86% | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
| Milestone Payments | 1.00M | 1.00M | 1.00M | - | - | 1.50M | 1.50M | 1.75M | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
| Milestone Payments Growth | - | -33.33% | -33.33% | - | - | 500.00% | - | - | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |